Nonetheless, both these responses must be tightly regulated,19 and the impaired BBB upregulates the expression of program death ligand 1/2 (PD‐L1/PD‐L2) to inhibit the effector T cell activation, thus inhibiting the adaptive immune response in glioma patients. The gene discussed is CD274; the disease is central nervous system cancer.